Cash on Hand for Merck & Co. (MRK)
According to Merck & Co.'s latest reported financial statements, the company's latest reported cash and short-term investments is $14.56B USD. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for a net cash/debt picture and with total assets for the share of assets held in cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
MRK
Currently viewingCash on HandSwitch metric
Latest period
$14.56B
YoY change
+6.4%
5Y CAGR
+12.6%
Peak year (2013)
$17.49B
Latest annual
$14.56B
Cash on Hand history chart for Merck & Co. (MRK) from 1985 to 2025
Cash on Hand history table for Merck & Co. (MRK) from 1985 to 2025
| Fiscal year | Period ended | Reported | Cash on Hand | YoY |
|---|---|---|---|---|
| 2025 | $14.56B | +6.4% | ||
| 2024 | $13.69B | +93.0% | ||
| 2023 | $7.09B | -46.2% | ||
| 2022 | $13.19B | +62.9% | ||
| 2021 | $8.10B | +0.6% | ||
| 2020 | $8.05B | -23.0% | ||
| 2019 | $10.45B | +17.9% | ||
| 2018 | $8.86B | +4.3% | ||
| 2017 | $8.50B | -40.7% | ||
| 2016 | $14.34B | +6.8% | ||
| 2015 | $13.43B | -14.6% | ||
| 2014 | $15.72B | -10.1% | ||
| 2013 | $17.49B | +8.3% | ||
| 2012 | $16.14B | +7.8% | ||
| 2011 | $14.97B | +22.7% | ||
| 2010 | $12.20B | +27.0% | ||
| 2009 | $9.60B | +75.1% | ||
| 2008 | $5.49B | -33.3% | ||
| 2007 | $8.23B | -5.5% | ||
| 2006 | $8.71B | -44.3% | ||
| 2005 | $15.64B | +120.6% | ||
| 2004 | $7.09B | +69.9% | ||
| 2003 | $4.17B | -16.1% | ||
| 2002 | $4.97B | +51.3% | ||
| 2001 | $3.29B | -22.8% | ||
| 2000 | $4.25B | +32.9% | ||
| 1999 | $3.20B | +22.9% | ||
| 1998 | $2.61B | +131.6% | ||
| 1997 | $1.13B | -16.8% | ||
| 1996 | $1.35B | -26.8% | ||
| 1995 | $1.85B | +15.2% | ||
| 1994 | $1.60B | +93.4% | ||
| 1993 | $829.40M | +44.2% | ||
| 1992 | $575.10M | -27.9% | ||
| 1991 | $797.90M | -1.1% | ||
| 1990 | $806.40M | +17.7% | ||
| 1989 | $685.10M | -55.8% | ||
| 1988 | $1.55B | +35.0% | ||
| 1987 | $1.15B | +18.9% | ||
| 1986 | $965.80M | +14.7% | ||
| 1985 | $842.00M | — |
Cash on Hand values are taken from Merck & Co.'s reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Merck & Co. (MRK) most recent annual cash and short-term investments stands at $14.56B (2025) – grew 6.4% year-over-year.
Merck & Co. cash and short-term investments compound annual growth for the 2020–2025 (5 years) window is +12.6%, sustaining 2 straight years of year-over-year growth.
Merck & Co. cash and short-term investments declined from $17.49B in 2013 to $14.56B in 2025, a 16.7% drawdown.
$17.49B stands as the all-time-high annual cash and short-term investments, posted in 2013, against a low of $575.10M during 1992.
Within Healthcare, Merck & Co. (MRK) ranks 4th among 8 peers we track. The peer median for cash and short-term investments is $9.62B.
Merck & Co. Cash on Hand by Year
Merck & Co. Cash on Hand 2025: $14.56B
Merck & Co. cash and short-term investments in 2025 was $14.56B, grew 6.4% from 2024.
Merck & Co. Cash on Hand 2024: $13.69B
Merck & Co. cash and short-term investments in 2024 was $13.69B, surged 93.0% from 2023.
Merck & Co. Cash on Hand 2023: $7.09B
Merck & Co. cash and short-term investments in 2023 was $7.09B, plunged 46.2% below 2022.
Merck & Co. Cash on Hand 2022: $13.19B
Merck & Co. cash and short-term investments in 2022 was $13.19B, surged 62.9% from 2021.
Merck & Co. Cash on Hand 2021: $8.10B
Merck & Co. cash and short-term investments in 2021 was $8.10B.
See more financial history for Merck & Co. (MRK).
Sector peers — Cash on Hand
Companies in the same sector as Merck & Co., ranked by their latest cash and short-term investments.
| Company | Cash on Hand | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $28.12B | Healthcare |
| Novo Nordisk A/S (NVO) | $26.96B | Healthcare |
| Johnson & Johnson (JNJ) | $20.10B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $10.11B | Healthcare |
| Amgen Inc. (AMGN) | $9.13B | Healthcare |
| Eli Lilly and Company (LLY) | $7.27B | Healthcare |
| AstraZeneca PLC (AZN) | $5.74B | Healthcare |
| AbbVie Inc. (ABBV) | $5.26B | Healthcare |
Frequently asked questions
What is Merck & Co.'s cash and short-term investments?
- Latest reported cash and short-term investments for Merck & Co. (MRK) is $14.56B (period ending December 31, 2025).
How has Merck & Co. cash and short-term investments changed year-over-year?
- Merck & Co. (MRK) cash and short-term investments changed +6.4% year-over-year on the latest annual filing.
What is the long-term growth rate of Merck & Co. cash and short-term investments?
- Merck & Co. (MRK) cash and short-term investments compound annual growth rate is +12.6% over the most recent 5 years available.
When did Merck & Co. cash and short-term investments hit its highest annual value?
- Merck & Co. cash and short-term investments reached its highest annual value of $17.49B in 2013.
What was Merck & Co. cash and short-term investments in 2024?
- Merck & Co. (MRK) cash and short-term investments in 2024 was $13.69B.
What was Merck & Co. cash and short-term investments in 2025?
- Merck & Co. (MRK) cash and short-term investments in 2025 was $14.56B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
MRK Overview
Company profile, financial tools, and key metrics
MRK Revenue Counter
Earns $2,061 every second. See per minute, hour, and day.
MRK Earnings Counter
Earns $578.83 per second net profit. See per minute, hour, and day.
MRK Economic Scale
Exceeds Bolivia's GDP. Compare with world economies.
MRK What If Invested
What if you had invested $1,000? See historical returns from any date.
MRK How It Makes Money
Discover visual breakdown of $65.01B in revenue — where it comes from and where it goes.
MRK Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
MRK Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
MRK Daily Price Character
Steady · 48.2% historical win rate (green days). Streaks & record days.
MRK Buybacks
2.39% TTM buyback yield. Shareholder yield & SBC comparison.
MRK Stock Split History
7 splits on record. Dates, ratios, and cumulative multiple.
MRK Dividend Profile
Yield: 2.99%. Safety: 8/8. See full history.
MRK Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
MRK Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.